Similarly, murine MSCs with CD73+ and CD34+ EVs have been shown to reverse graft-versus-host disease (GvHD) and hindlimb ischemia by suppressing Th1-mediated inflammation (Amarnath et al., 2015). Here, CD34 is linked to graft versus host disease.